Xiaoteng Cui

发表

lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy

Chunsheng Kang, Yuhao Zhang, Chuan Fang, 2022, Frontiers in Oncology.

Phosphatidylcholine-Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery.

Jin Zhao, C. Kang, Xubo Yuan, 2021, Macromolecular bioscience.

Phosphorylation of Tudor-SN, a novel substrate of JNK, is involved in the efficient recruitment of Tudor-SN into stress granules.

Jie Yang, W. Shui, Lixin Li, 2017, Biochimica et biophysica acta. Molecular cell research.

Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma

C. Kang, Yunfei Wang, Junhu Zhou, 2021, Molecular Therapy.

Poly(A)+ mRNA‐binding protein Tudor‐SN regulates stress granules aggregation dynamics

O. Silvennoinen, Z. Yao, Jie Shao, 2015, The FEBS journal.

Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients

Z. Yao, Jie Yang, Shaoyuan Wu, 2021, BMC Cancer.

Malonate induces the assembly of cytoplasmic stress granules

Wei Zhang, Z. Yao, Jie Yang, 2016, FEBS letters.

Translation of Tudor-SN, a novel terminal oligo-pyrimidine (TOP) mRNA, is regulated by the mTORC1 pathway in cardiomyocytes

Jie Yang, Xiaoteng Cui, M. Wei, 2020, RNA biology.

A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors.

Jie Yang, Xiaoteng Cui, Xiaoming Sun, 2020, Genomics.

RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner

Chao Yang, C. Kang, Hua You, 2019, Cell Death & Disease.

Integrative analysis regarding the correlation between GAS2 family genes and human glioma prognosis

N. Zhang, Jie Yang, Xiaoteng Cui, 2021, Cancer medicine.

LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis

C. Kang, Xing Liu, Chuan Fang, 2021, Theranostics.

MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.

Qi-xue Wang, Jixing Zhao, Xiaoteng Cui, 2022, Pharmacological research.

PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma

C. Kang, Xing Liu, Chuan Fang, 2022, Frontiers in Immunology.

PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma

Chunsheng Kang, Xing Liu, Chuan Fang, 2022, Theranostics.

Differential genetic mutations of ectoderm, mesoderm, and endoderm-derived tumors in TCGA database

Jie Yang, Shaoyuan Wu, Xiaoteng Cui, 2020, Cancer Cell International.

Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage

C. Kang, Yunfei Wang, Junhu Zhou, 2021, Frontiers in Oncology.

Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice

Jie Yang, Xiaoteng Cui, L. Xin, 2021, Bioengineered.

Growth arrest–specific 2 protein family: Structure and function

N. Zhang, Jie Yang, Xiaoteng Cui, 2020, Cell proliferation.

A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.

Chunsheng Kang, Yanli Tan, Qi-xue Wang, 2022, Neuro-oncology.

TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma

Chunsheng Kang, Chuan Fang, Yanli Tan, 2022, Theranostics.

SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma

Z. Yao, Jie Yang, Xiaoteng Cui, 2018, RNA biology.

Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor

Z. Yao, Yuanbo Wang, Jie Yang, 2020, Science Advances.

Editorial: Innovative theranostic approaches towards neuro-immunology in gliomas

Chunsheng Kang, Xiaoteng Cui, Lijie Zhai, 2023, Frontiers in Immunology.

Expert opinion on translational research for advanced glioblastoma treatment

Chunsheng Kang, Yunfei Wang, Junhu Zhou, 2023, Cancer biology & medicine.

EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT.

Chunsheng Kang, Chuan Fang, Yanli Tan, 2023, Neuro-oncology.

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance

C. Kang, Yunfei Wang, Guang-xiu Wang, 2023, Cancer biology & medicine.

Phosphorylation of Tudor-SN, a novel substrate of JNK, is involved in the efficient recruitment of Tudor-SN into stress granules.

Jie Yang, W. Shui, Lixin Li, 2017, Biochimica et biophysica acta. Molecular cell research.

Differential genetic mutations of ectoderm, mesoderm, and endoderm-derived tumors in TCGA database

N. Zhang, Jie Yang, Shaoyuan Wu, 2020, Cancer cell international.

Deep‐targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma

Chuan Fang, Yanli Tan, Can Xu, 2024, CNS neuroscience & therapeutics.

CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma

Yunfei Wang, Junhu Zhou, Jixing Zhao, 2024, Theranostics.

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.

Yunfei Wang, Jixing Zhao, Xiaoteng Cui, 2024, Cancer letters.

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma

Chunsheng Kang, Guanzhang Li, Chuan Fang, 2023, Cancer communications.

Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a provides a personalized therapeutic strategy for the treatment of human glioblastoma.

C. Kang, Yanli Tan, Yunfei Wang, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.